Compliance with Scopus Policies

The journal of Strategic Management of Organizational Knowledge (SMOK) aligns its editorial, ethical, and publication practices with the Scopus Content Policy and Selection Criteria. The journal maintains transparent editorial processes, rigorous peer review, ethical publishing standards, and clear policies governing the responsible use of Generative Artificial Intelligence (GenAI) in research and scholarly publishing.

(Scopus content policy and selection | Elsevier)

Purpose

The SMOK recognizes the growing role of Generative Artificial Intelligence (GenAI) technologies in academic research and scholarly communication. While these technologies can support authors, reviewers, and editors in improving efficiency and language quality, their use must be transparent, ethical, and consistent with the principles of research integrity.

This policy establishes the journal’s requirements regarding the acceptable use of GenAI tools in manuscript preparation, peer review, editorial activities, and publication processes.

 

1. Use of GenAI by Authors

Authors may use GenAI tools (e.g., ChatGPT, Gemini, Claude, Copilot, or similar systems) for limited purposes such as:

• Language editing and grammar improvement;
• Improving readability and clarity of text;
• Formatting assistance;
• Coding support and data-processing assistance;
• Generating preliminary summaries or outlines.

However, authors remain fully responsible for:

• The accuracy, originality, and integrity of all submitted content;
• Verification of facts, data, references, analyses, and interpretations;
• Compliance with ethical and legal requirements, including copyright and confidentiality.

GenAI systems cannot be listed as authors or co-authors because they cannot assume responsibility for the content of a scholarly work.

 

2. Mandatory Disclosure of GenAI Use

Authors must disclose any substantive use of GenAI in the preparation of a manuscript.

The disclosure should include:

• Name of the GenAI tool;
• Version (if applicable);
• Purpose of use;
• Extent of contribution.

A disclosure statement should be included in a separate section before the References.

 

Example Disclosure Statement

“The authors used ChatGPT (OpenAI, GPT-5) to improve language clarity and assist in the initial organization of manuscript sections. All generated content was reviewed, revised, and verified by the authors, who take full responsibility for the final manuscript.”

Failure to disclose significant use of GenAI may constitute a breach of publication ethics.

 

3. Prohibited Uses by Authors

The following uses are not permitted:

• Fabrication or falsification of data, results, citations, or references;
• Generation of misleading scientific claims;
• Submission of AI-generated content without human verification;
• Use of GenAI to create fictitious sources or unsupported evidence;
• Attribution of authorship to any AI system.

The editorial office may request clarification or supporting documentation regarding the use of GenAI.

 

4. Use of GenAI by Reviewers

Reviewers must maintain strict confidentiality of manuscripts.

Reviewers are prohibited from:

• Uploading submitted manuscripts or reviewer reports into public or third-party GenAI systems;
• Using GenAI tools to generate peer-review decisions;
• Sharing confidential manuscript content with AI systems that may retain, learn from, or redistribute such information.

Peer-review judgments must be made solely by human reviewers.

 

5. Use of GenAI by Editors

Editors may use GenAI tools only for limited administrative purposes such as:

• Language improvement;
• Workflow support;
• Metadata organization;
• Preliminary technical screening.

Editorial decisions, evaluations of scientific merit, acceptance, rejection, and ethical assessments must be conducted exclusively by human editors.

 

6. Research Involving GenAI

Manuscripts that investigate, evaluate, develop, or apply GenAI technologies are welcome within the scope of the journal, provided that:

• Methods are clearly described;
• Training data and model information are reported when available;
• Ethical considerations are adequately addressed;
• Results are reproducible and verifiable.

7. Editorial Investigation

The journal reserves the right to:

• Request additional information regarding the use of GenAI;
• Screen manuscripts using appropriate tools and editorial procedures;
• Reject submissions that violate this policy;
• Correct or retract published articles where undisclosed or inappropriate use of GenAI is identified.

8. Alignment with International Standards

This policy is informed by recommendations and guidance issued by:

• Elsevier and Scopus;
• Committee on Publication Ethics (COPE);
• World Association of Medical Editors (WAME);
• STM Association guidelines on AI-assisted scholarly writing.

 

Policy Review

Given the rapid evolution of Generative AI technologies, this policy may be updated periodically by the Editorial Board of the SMOK.